101 related articles for article (PubMed ID: 3898748)
1. Risk factors for the development of premature cardiovascular disease.
Brewer HB; Sprecher DL; Gregg RE; Hoeg JM
Adv Exp Med Biol; 1985; 183():27-36. PubMed ID: 3898748
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease.
Brewer HB
Am J Cardiol; 1999 May; 83(9B):3F-12F. PubMed ID: 10357568
[TBL] [Abstract][Full Text] [Related]
4. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.
Laudanski K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638860
[TBL] [Abstract][Full Text] [Related]
7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
[TBL] [Abstract][Full Text] [Related]
9. Current, new and future treatments in dyslipidaemia and atherosclerosis.
Chong PH; Bachenheimer BS
Drugs; 2000 Jul; 60(1):55-93. PubMed ID: 10929930
[TBL] [Abstract][Full Text] [Related]
10. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
11. Transfer of free and esterified cholesterol from low-density lipoproteins and high-density lipoproteins to human adipocytes.
Fong BS; Angel A
Biochim Biophys Acta; 1989 Jul; 1004(1):53-60. PubMed ID: 2742874
[TBL] [Abstract][Full Text] [Related]
12. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
13. [Various lipoprotein fractions and their relation to ischemic heart disease].
Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
[TBL] [Abstract][Full Text] [Related]
14. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
15. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
Parhofer KG
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
[TBL] [Abstract][Full Text] [Related]
16. Management of the patient with a low HDL-cholesterol.
Leighton RF
Clin Cardiol; 1990 Aug; 13(8):521-32. PubMed ID: 2204505
[TBL] [Abstract][Full Text] [Related]
17. Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trials.
Kühnast S; Fiocco M; van der Hoorn JW; Princen HM; Jukema JW
Eur J Pharmacol; 2015 Sep; 763(Pt A):48-63. PubMed ID: 25989133
[TBL] [Abstract][Full Text] [Related]
18. Triglycerides and cardiovascular disease.
Nordestgaard BG; Varbo A
Lancet; 2014 Aug; 384(9943):626-635. PubMed ID: 25131982
[TBL] [Abstract][Full Text] [Related]
19. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
20. HDL cholesterol: reappraisal of its clinical relevance.
März W; Kleber ME; Scharnagl H; Speer T; Zewinger S; Ritsch A; Parhofer KG; von Eckardstein A; Landmesser U; Laufs U
Clin Res Cardiol; 2017 Sep; 106(9):663-675. PubMed ID: 28342064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
